InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,224.09
(
0.19%
)
US TECH 100
17,688.80
(
0.27%
)
Dow Jones
39,537.91
(
0.38%
)
Brent Oil
82.75
(
-1.43%
)
Bitcoin
60,675.14
(
-3.76%
)
Post# of 307
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Fenix1357

Send PM Follow Ignore
Followers 3
Posts 45
Boards Moderated 0
Alias Born 01/19/2011

Fenix1357

Re: Fenix1357 post# 184

Sunday, 10/06/2019 7:20:29 PM

Sunday, October 06, 2019 7:20:29 PM

Post# of 307
The fact that I can not find any published papers on the phase two trial for back pain worry me, imply there were some flaws in the study which kept them from publishing the paper or being accepted by scientific journals. They have no p values published either
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent MESO News
More MESO News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!